2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92542°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...
¾¾¾Ø¿¡½ºÆÄ¿ö, Ä¿³×ƽ Â÷·®¿ë °í¼Ó ¹«¼± ÃæÀü °ÅÄ¡´ë (2019-04-18)
»êºÒ ÁøÈ­ ÇöÀåÀÇ ¡®¼ûÀº ÁÖÀΰø¡¯ ÀÚ¿øºÀ»çÀÚ (2022-06-13)
ÁßÀå³â 85%, ÀºÅð ÈÄ »ýȰºñ ºÎÁ·Çصµ ºÎµ¿»ê º¸À¯ (2016-01-23)
LG»ýȰ°Ç°­, '¸®Ä¡' ±¸°­¿ëǰ 9Á¾ Ãâ½Ã (2017-02-08)
2017³â ¶óÀÌ¡½ºÅ¸ '³¶¸¸´ÚÅÍ' ±èº¸Á¤ (2017-01-10)
3ºÐ±â °ÇÃà ÀÎÇã°¡ ¸éÀû, Àü³âµ¿±â ´ëºñ 52.3% Áõ°¡ (2015-10-28)
±¸Á÷ÀÚ 42.1% ¡®Áߺ¹ ÇÕ°Ý °æÇè ÀÖ´Ù¡¯ (2015-05-13)
UÆÑ ½ºÀ§ÇÁÆ®(SWIFT)º¸Á¶¹èÅ͸® 1¡¤2¸¸ ¸ðµ¨ Ãâ½Ã (2018-05-17)
¾÷°è ÃÖÃÊÀÇ ÀÚµ¿Â÷¿ë SiC 6ÆÑ Àü·Â ¸ðµâ (2021-05-21)
S-OIL, »þÈù ÇÁ·ÎÁ§Æ®·Î ¼®À¯È­ÇÐ ´ëÀüȯ (2023-03-12)
±è°æÈ­, ¡®Ç䡯 ¼Ò¸®³ª´Â ¸íǰ º¹±Ù (2016-06-27)
°¡Àå °­·ÂÇÑ ºí·¢¹Ú½º°¡ ³ª¿Ô´Ù (2013-02-04)
Çö´ëÂ÷, ½ÅÇü º§·Î½ºÅÍ ¹Ìµð¾î ÇÁ¸®ºä °³ÃÖ (2017-11-30)
°ø°ø±â°ü ÃÊÀÓ¿¬ºÀ 1À§, Çѱ¹°úÇбâ¼ú¿ø 5,059¸¸¿ø (2018-01-21)
Æ÷½ºÅØ, ¡®ºñÁ¢ÃË½Ä ±¤Ä¿³ØÅÍ¡¯ Â÷¼¼´ë ¼¼°èÀÏ·ù»óǰ (2017-11-24)
Å©¶ó¿ìµåÆÝµù, º¥Ã³±â¾÷ ¡®µ·°¡¹³¡¯¿¡ ´ÜºñµÇ¾î ³»¸®´Ù (2014-03-10)
¡®Ä¢-¡®ÇÏ´Â »ç¿îµå¿Í Â÷½Â¿øÀÇ 'Åå' ½î´Â ¸Å·Â (2015-12-30)
¿­Á¤À¸·Î ¹ãÀ» °È´Â ¹«¹Ú 2ÀÏ °È±â´ëȸ (2022-07-29)
Çö´ë°Ç¼³, ÀÎõ±¹Á¦°øÇ×°ø»ç µî Á÷¿ø ä¿ë (2021-07-06)
LGÀüÀÚ, ¹Ì±¹ ¹Ì½Ã°ÇÁÖ¿¡ Àü±âÂ÷ ºÎǰ °øÀå ¼³¸³ (2017-08-23)
¹«Àλ¡·¡¹æ¿¡ Äڷγª19 ¿Â¶óÀÎ ÃâÀÔ¸íºÎ Áö¿ø (2021-06-07)
³×°íÇÁ¶óÀ̽º, ±¹³»ÃÖÃÊ ¡®°¡°Ý ÈïÁ¤¡¯ ±â´É µµÀÔ (2016-03-14)
Çѱ¹ ȯÀ² Á¤Ã¥ °æ°íµî (2016-02-14)
±â¾ÆÂ÷, ¡®±â¾Æ µå¶óÀ̺ù °¡À̵塯 Á¦ÀÛ (2016-03-08)
½Ö¿ëC&B, ¹Ì¼¼¸ÕÁö¡¤È²»ç¸¶½ºÅ© ½ÅÁ¦Ç° 3Á¾ (2018-02-24)
       [ÀÌÀü][1]....[1661][1662][1663][1664][1665][1666][1667][1668][1669]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..